EAU 2013 - Programme Book - YouMed

Sponsored Sessions
Saturday, 16 March
404 Programme Book
Sponsored Session
18.00 - 19.30 Risk stratification to optimize the management of men with
symptomatic BPH at risk of progression
Platinum Hall - Level S3
Symposium
Chair: V. Mirone, Naples (IT)
Session outline
V. Mirone, Naples (IT)
Why is BPH progression important and how can we use risk factors to identify patients at risk of
progression?
M. Marberger, Vienna (AT)
What is the evidence for treating patients with BPH based on their risk of progression?
M. Emberton, London (GB)
Benefit/risk of treatments for patients with BPH at risk of progression
G. Andriole, St. Louis (US)
Case study discussions: Implications in daily practice for BPH management
Q&A session
Aims and objectives
To evaluate and argue on the risk/benefit profile of currently recommended medical treatment options for
patients at risk of BPH progression debating the most recent scientific evidence and with a focus to the latest
evidence on risk factors that categorize BPH as a progressive disease and risk stratification that allows the
right allocation of treatment to patients
Sponsored by GLAXOSMITHKLINE